Alok K. Tewari

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Transcriptional mediators of treatment resistance in lethal prostate cancer”.

Transcriptional mediators of treatment resistance in lethal prostate cancer

Nature Medicine(2021)10.1038/s41591-021-01244-6

N/A

4.8DataRank · unranked

196 citations

Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi +35 more

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

Nature Communications(2021)10.1038/s41467-021-26042-z

N/A

2.9DataRank · unranked

163 citations

Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu +33 more

Transcriptional mediators of treatment resistance in lethal prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.19.998450

N/A

1.0DataRank · unranked

26 citations

Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi +22 more

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Cancer Cell(2021)10.1016/j.ccell.2021.02.015

N/A

0.964DataRank · unranked

617 citations

Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Jingyi Wu +26 more

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0812

N/A

0.848DataRank · unranked

284 citations

Wubing Zhang, Xiaoqing Wang, Peng Jiang, Nicole Traugh, Ziyi Li +28 more

Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer

(2020)10.1101/2020.09.13.291328

N/A

0.464DataRank · unranked

21 citations

Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu +30 more

A patient-driven clinicogenomic partnership for metastatic prostate cancer

Cell Genomics(2022)10.1016/j.xgen.2022.100169

N/A

0.460DataRank · unranked

10 citations

Sara Balch, Lauren Sterlin, Beena Thomas, Sabrina Y. Camp, Michael Dunphy +27 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014

N/A

0.442DataRank · unranked

18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer

Nature Communications(2025)10.1038/s41467-025-60654-z

N/A

0.373DataRank · unranked

11 citations

Sheng-Yu Ku, Varadha Balaji Venkadakrishnan, Martin Bakht, Michael Sigouros, Joanna Chan +18 more

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.20.440657

N/A

0.349DataRank · unranked

7 citations

Alexander T. M. Cheung, Jett Crowdis, Jake R. Conway, Sabrina Y. Camp, Stephanie A. Wankowicz +15 more

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Cancer Cell(2025)10.1016/j.ccell.2025.05.009

N/A

0.330DataRank · unranked

8 citations

Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Jingyi Wu +25 more

A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.01.011

N/A

0.330DataRank · unranked

8 citations

D. Gulhan, Hunter Savignano, Gitanjali Lakshminarayanan, Heather M. McClure, Rebecca Silver +8 more

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer

European Urology Oncology(2025)10.1016/j.euo.2024.10.014

N/A

0.306DataRank · unranked

3 citations

Caiwei Zhong, Wanling Xie, Emma Kelly, Bridget Whelpley, Katelyn Kuczmarski +13 more

Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data

Genome Research(2022)10.1101/gr.272203.120

N/A

0.208DataRank · unranked

3 citations

Jianling Zhong, Alexias Safi, Linda K. Hong, Alok K. Tewari, Lingyun Song +5 more

Quantitative occupancy of myriad transcription factors from one DNase experiment enables efficient comparisons across conditions

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.28.171587

N/A

0.165DataRank · unranked

2 citations

Jianling Zhong, Alexias Safi, Linda K. Hong, Alok K. Tewari, Lingyun Song +5 more

A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer

The Prostate(2024)10.1002/pros.24788

N/A

0.165DataRank · unranked

2 citations

Alok K. Tewari, D. Gulhan, Ziad Bakouny, Guruprasad Ananda, Hunter Savignano +8 more

Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.02.657429

N/A

0.165DataRank · unranked

2 citations

Esmé Wheeler, Rong Li, Feng Lü, Buraq Ahmed, Alok K. Tewari +8 more

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.700

N/A

0.104DataRank · unranked

1 citations

Wubing Zhang, Xiaoqing Wang, Peng Jiang, Nicole Traugh, Ziyi Li +28 more

A patient-driven clinicogenomic partnership through the Metastatic Prostate Cancer Project

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.09.451849

N/A

0.104DataRank · unranked

1 citations

Sara Balch, Lauren Sterlin, Beena Thomas, Sabrina Y. Camp, Michael Dunphy +27 more

Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.15.654324

N/A

0.104DataRank · unranked

1 citations

Anwar Abdelnaser, Jeremiah A. Wala, Alexander J Haas, Alfred A. Barney, Eddy Saad +12 more

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer

Cell Reports(2021)10.1016/j.celrep.2021.109665

N/A

0DataRank · unranked

41 citations

Alexander T. M. Cheung, Jett Crowdis, Jake R. Conway, Sabrina Y. Camp, Stephanie A. Wankowicz +15 more